Artificial heart offers lifeline to patients waiting for transplant
NCT ID NCT04475393
Summary
This study is testing a new type of total artificial heart (the Carmat TAH) for people with severe, irreversible heart failure who are waiting for a heart transplant. The device is meant to keep patients alive and stable until a donor heart becomes available. Researchers will compare outcomes for patients who receive the artificial heart to those who receive standard medical care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHRU Montpellier
Montpellier, 34090, France
-
CHU Dijon
Dijon, 21000, France
-
Centre Hospitalier Régional Universitaire
Lille, 59000, France
-
Groupe Hospitalier Pitié-Salpêtrière,
Paris, 75013, France
-
Hôpital Européen George Pompidou
Paris, 75015, France
-
Hôpital Laennec
Nantes, 44093, France
-
Hôpital Louis Pradel
Bron, 69500, France
-
Hôpital Marie Lannelongue
Le Plessis-Robinson, 92350, France
-
Hôpital Pontchaillou
Rennes, 35033, France
-
Nouvel Hôpital Civil
Strasbourg, 67000, France
Conditions
Explore the condition pages connected to this study.